BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brogi S, Ramunno A, Savi L, Chemi G, Alfano G, Pecorelli A, Pambianchi E, Galatello P, Compagnoni G, Focher F, Biamonti G, Valacchi G, Butini S, Gemma S, Campiani G, Brindisi M. First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents. Eur J Med Chem 2017;138:438-57. [PMID: 28689095 DOI: 10.1016/j.ejmech.2017.06.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Brogi S. Computational Approaches for Drug Discovery. Molecules 2019;24:E3061. [PMID: 31443558 DOI: 10.3390/molecules24173061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
2 Lu S, He X, Ni D, Zhang J. Allosteric Modulator Discovery: From Serendipity to Structure-Based Design. J Med Chem 2019;62:6405-21. [DOI: 10.1021/acs.jmedchem.8b01749] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 19.0] [Reference Citation Analysis]
3 Silva GM, Borges RS, Santos KLB, Federico LB, Francischini IAG, Gomes SQ, Barcelos MP, Silva RC, Santos CBR, Silva CHTP. Revisiting the Proposition of Binding Pockets and Bioactive Poses for GSK-3β Allosteric Modulators Addressed to Neurodegenerative Diseases. Int J Mol Sci 2021;22:8252. [PMID: 34361017 DOI: 10.3390/ijms22158252] [Reference Citation Analysis]
4 Gabr MT, Brogi S. MicroRNA-Based Multitarget Approach for Alzheimer's Disease: Discovery of the First-In-Class Dual Inhibitor of Acetylcholinesterase and MicroRNA-15b Biogenesis. J Med Chem 2020;63:9695-704. [PMID: 32787143 DOI: 10.1021/acs.jmedchem.0c00756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Fernandez RA, Quimque MT, Notarte KI, Manzano JA, Pilapil DY 4th, de Leon VN, San Jose JJ, Villalobos O, Muralidharan NH, Gromiha MM, Brogi S, Macabeo APG. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein. J Biomol Struct Dyn 2021;:1-12. [PMID: 34463219 DOI: 10.1080/07391102.2021.1969281] [Reference Citation Analysis]
6 Carullo G, Federico S, Relitti N, Gemma S, Butini S, Campiani G. Retinitis Pigmentosa and Retinal Degenerations: Deciphering Pathways and Targets for Drug Discovery and Development. ACS Chem Neurosci 2020;11:2173-91. [DOI: 10.1021/acschemneuro.0c00358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Brogi S, Sirous H, Calderone V, Chemi G. Amyloid β fibril disruption by oleuropein aglycone: long-time molecular dynamics simulation to gain insight into the mechanism of action of this polyphenol from extra virgin olive oil. Food Funct 2020;11:8122-32. [DOI: 10.1039/d0fo01511c] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Grillo A, Fezza F, Chemi G, Colangeli R, Brogi S, Fazio D, Federico S, Papa A, Relitti N, Di Maio R, Giorgi G, Lamponi S, Valoti M, Gorelli B, Saponara S, Benedusi M, Pecorelli A, Minetti P, Valacchi G, Butini S, Campiani G, Gemma S, Maccarrone M, Di Giovanni G. Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents. ACS Chem Neurosci 2021;12:1716-36. [PMID: 33890763 DOI: 10.1021/acschemneuro.1c00192] [Reference Citation Analysis]
9 Chen H, Zhang X, Zhang X, Fan Z, Liu W, Lei Y, Zhu C, Ma B. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity. Bioorg Med Chem 2020;28:115699. [PMID: 33069078 DOI: 10.1016/j.bmc.2020.115699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Federico S, Khan T, Relitti N, Chemi G, Brindisi M, Brogi S, Novellino E, Zisterer DM, Campiani G, Gemma S, Butini S. A Jocic-type approach for a practical and scalable synthesis of pyrrolonaphthoxazepine (PNOX)-based potent proapoptotic agents. Tetrahedron Letters 2018;59:4466-70. [DOI: 10.1016/j.tetlet.2018.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Li J, Fu Q, Liang Y, Cheng B, Li X. Microsecond molecular dynamics simulations and dynamic network analysis provide understanding of the allosteric inactivation of GSK3β induced by the L343R mutation. J Mol Model 2019;25. [DOI: 10.1007/s00894-019-4003-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Liu S, Xie H, Ge Y, Zhang J, Jiang C. An updated research of glycogen synthase kinase-3β inhibitors: a review. Monatsh Chem 2021;152:19-33. [DOI: 10.1007/s00706-020-02718-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Grillo A, Chemi G, Brogi S, Brindisi M, Relitti N, Fezza F, Fazio D, Castelletti L, Perdona E, Wong A, Lamponi S, Pecorelli A, Benedusi M, Fantacci M, Valoti M, Valacchi G, Micheli F, Novellino E, Campiani G, Butini S, Maccarrone M, Gemma S. Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems. European Journal of Medicinal Chemistry 2019;183:111674. [DOI: 10.1016/j.ejmech.2019.111674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Relitti N, Saraswati AP, Chemi G, Brindisi M, Brogi S, Herp D, Schmidtkunz K, Saccoccia F, Ruberti G, Ulivieri C, Vanni F, Sarno F, Altucci L, Lamponi S, Jung M, Gemma S, Butini S, Campiani G. Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation. Eur J Med Chem 2021;212:112998. [PMID: 33199154 DOI: 10.1016/j.ejmech.2020.112998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hromádka R, Kejík Z, Jakubek M, Kaplánek R, Šandriková V, Urban M, Martásek P, Král V. Pigments from Filamentous Ascomycetes for Combination Therapy. Curr Med Chem 2019;26:3812-34. [PMID: 29600749 DOI: 10.2174/0929867325666180330091933] [Reference Citation Analysis]
16 De Simone A, Tumiatti V, Andrisano V, Milelli A. Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery? J Med Chem 2021;64:26-41. [PMID: 33346659 DOI: 10.1021/acs.jmedchem.0c00931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Mondal SK, Mukhoty S, Kundu H, Ghosh S, Sen MK, Das S, Brogi S. In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs. Comput Biol Med 2021;135:104591. [PMID: 34216889 DOI: 10.1016/j.compbiomed.2021.104591] [Reference Citation Analysis]
18 Brindisi M, Borrelli G, Brogi S, Grillo A, Maramai S, Paolino M, Benedusi M, Pecorelli A, Valacchi G, Di cesare mannelli L, Ghelardini C, Allarà M, Ligresti A, Minetti P, Campiani G, di Marzo V, Butini S, Gemma S. Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain. ChemMedChem 2018;13:2090-103. [DOI: 10.1002/cmdc.201800397] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
19 Sirous H, Chemi G, Gemma S, Butini S, Debyser Z, Christ F, Saghaie L, Brogi S, Fassihi A, Campiani G, Brindisi M. Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach. Front Chem 2019;7:574. [PMID: 31457006 DOI: 10.3389/fchem.2019.00574] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]